Piper Jaffray Upgrades ISIS Pharmaceuticals (ISIS) to Neutral
Tweet Send to a Friend
Piper Jaffray upgraded ISIS Pharmaceuticals (NASDAQ: ISIS) from Underweight to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
